Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Zevra Therapeutics

9.99
-0.1900-1.87%
Post-market: 10.050.0600+0.60%19:48 EDT
Volume:951.87K
Turnover:9.52M
Market Cap:590.56M
PE:10.40
High:10.24
Open:10.24
Low:9.85
Close:10.18
52wk High:15.04
52wk Low:8.01
Shares:59.11M
Float Shares:53.86M
Volume Ratio:0.81
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9602
EPS(LYR):1.35
ROE:34.80%
ROA:8.74%
PB:2.71
PE(LYR):7.40

Loading ...

OverviewCompanyNewsFilings

Rare disease drugmaker Zevra Therapeutics Q1 revenue jumps 78%

Reuters
·
May 07

Zevra Q1 FY26 net income swings to $37.9 million; revenue rises 78% to $36.2 million

Reuters
·
May 07

Zevra Therapeutics Q1 EPS $0.60 Beats $0.07 Estimate, Sales $36.220M Beat $31.960M Estimate

Benzinga Earnings
·
May 07

Ligand Pharma to acquire fellow biotech royalty rights buyer XOMA for $739 million

Reuters
·
Apr 27

Zevra Therapeutics schedules first-quarter results conference call

Reuters
·
Apr 22

BTIG Sticks to Their Buy Rating for Zevra Therapeutics (ZVRA)

TIPRANKS
·
Apr 06

Zevra Therapeutics announces annual shareholder meeting notice

Reuters
·
Apr 06

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 05, 2026 Post-Mkt
Financial Report Announcement
May 06, 2026 Post-Mkt
Financial Report Announcement
Mar 09, 2026 Post-Mkt
Financial Report Announcement
Nov 05, 2025 Post-Mkt
Financial Report Announcement
Aug 12, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

10.40
Current
-64.18
Sector Average
84.92%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
10.40
Maximum
241.61
+1 STD
245.63
Minimum
-1,802.34
-1 STD
-374.00
Average
-64.18

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.